Jung YJ, Lee S, Kang SK, Kim JY, et al. Clinicopathological factors predicting pathological complete response to neoadjuvant anti-HER2 therapy in HER2-positive breast cancer. Oncology 2024 Sep 9:1-16. doi: 10.1159/000541019.
PMID: 39250898